Trade Summary

1 month ago, Lederman Seth, serving as CEO at Tonix Pharmaceuticals Holding Corp. (TNXP), purchased 5,000 shares at $12.62 per share, for a total transaction value of $63,100.00. Following this transaction, Lederman Seth now holds 24,007 shares of TNXP.

This purchase represents a 26.00% increase in Lederman Seth's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 31, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 1, 2026, 1 day after the trade was made.

Tonix Pharmaceuticals Holding Corp. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.